# Tenaya Therapeutics, Inc.: Form 8-K, filed May 31, 2024

- Company: [Tenaya Therapeutics, Inc.](/companies/tnya.md) (CIK 1858848)
- Form: 8-K
- Filed: 2024-05-31
- Accepted by EDGAR: May 31, 2024, 16:13 ET
- Period: 2024-05-30
- Accession: 0000950170-24-067318
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1858848/000095017024067318/tnya-20240530.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1858848/000095017024067318/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1858848/000095017024067318/tnya-20240530.htm

Filed May 31, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-067318. Last ingested by Listed: Nov 4, 2026, 17:31 ET. No prices; not investment advice.